Human antibodies made in genetically engineered cows have proved safe in an early-stage clinical trial.
Laval, Quebec-based Valeant Pharmaceuticals International, Inc. (VRX) announced today that it will acquire Mercury (Cayman) Holdings, the holding company of Amoun Pharmaceutical, for about $800 million and contingent payments. Amoun […]
